26
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Efficacy of Three Different Injection Techniques for the Endoscopic Treatment of Vesicoureteral Reflux (VUR) in Children: A Review of 10 Years of Experience

, , , , , , , & show all
Pages 151-159 | Received 14 May 2024, Accepted 25 Jun 2024, Published online: 03 Jul 2024

References

  • Elder JS, Peters CA, Arant BS, et al. Pediatric vesicoureteral reflux guidelines panel summary report on the management of primary vesicoureteral reflux in children. J Urol. 1997;157(5):1846–1851. doi:10.1016/S0022-5347(01)64882-1
  • Zhang T, Wiygul J. Correlation not causation - looking back at the history of VUR. Urology. 2024;S009042952400445X. doi:10.1016/j.urology.2024.06.002
  • Boswell TC, Maric T, Khoury AE, Farrugia MK. Urinary tract dilatation and vesicoureteral reflux - Adult outcomes, who should be followed, and how to follow them. J Pediatric Urology. 2023;19(4):450–455. doi:10.1016/j.jpurol.2023.04.038
  • Nordenström J, Sjöström S, Dellenmark-Blom M. Parents’ experiences of treatment and outcomes in high-grade vesicoureteral reflux in infants – one piece in the puzzle of VUR management? J Pediatric Urology. 2024;S1477513124002845. doi:10.1016/j.jpurol.2024.05.020
  • Kutasy B, Coyle D. History of endoscopic treatment of vesicoureteral reflux. Pediatr Surg Int. 2023;39(1):187. doi:10.1007/s00383-023-05468-0
  • Escolino M, Kalfa N, Castagnetti M, et al. Endoscopic injection of bulking agents in pediatric vesicoureteral reflux: a narrative review of the literature. Pediatr Surg Int. 2023;39(1):133. doi:10.1007/s00383-023-05426-w
  • Chang CL, Yang SSD, Hsu CK, Chen CH, Chang SJ. Effectiveness of various treatment modalities in children with vesicoureteral reflux grades II–IV: a systematic review and network meta-analysis. BMJPO. 2023;7(1):e002096. doi:10.1136/bmjpo-2023-002096
  • Fanos V, Cataldi L. Antibiotics or surgery for vesicoureteric reflux in children. Lancet. 2004;364(9446):1720–1722. doi:10.1016/S0140-6736(04)17359-5
  • Kim SW, Lee YS, Han SW. Endoscopic injection therapy. Investig Clin Urol. 2017;58(Suppl 1):S38. doi:10.4111/icu.2017.58.S1.S38
  • Hajiyev P, Burgu B. Contemporary management of vesicoureteral reflux. European Urology Focus. 2017;3(2–3):181–188. doi:10.1016/j.euf.2017.08.012
  • Zvizdic Z, Catic A, Zivojevic S, Jonuzi A, Glamoclija U, Vranic S. The correlation between ureteric orifice morphology and primary vesicoureteral reflux grade and the impact on the effectiveness of endoscopic reflux correction. J Pediatric Urology. 2024;20(2):295–301. doi:10.1016/j.jpurol.2023.10.027
  • Matouschek E. Treatment of vesicorenal reflux by transurethral teflon-injection (author’s transl). Urologe A. 1981;20(5):263–264.
  • O’Donnell B, Puri P. Treatment of vesicoureteric reflux by endoscopic injection of Teflon. BMJ. 1984;289(6436):7–9. doi:10.1136/bmj.289.6436.7
  • Kirsch AJ, Perez-Brayfield M, Smith EA, Scherz HC. The modified sting procedure to correct vesicoureteral reflux: improved results with submucosal implantation within the intramural ureter. J Urol. 2004;171(6 Part 1):2413–2416. doi:10.1097/01.ju.0000127754.79866.7f
  • Capozza N, Caione P. Modification of the sting procedure for vesicoureteral reflux: ureteral repositioning and injection. Arch Esp Urol. 2008;61(2). doi:10.4321/S0004-06142008000200021
  • Garcia-Aparicio L, Martin-Sole O, Capdevila-Vilaro B, Perez-Bertolez S. Long-term outcome of randomized clinical trial between polyacrylate-polyalcohol copolymer (PPC) and dextranomer-hyaluronic acid copolymer (Dx/HA) as bulking agents for endoscopic treatment of primary vesicoureteral reflux (VUR). World J Urol. 2023;41(10):2855–2859. doi:10.1007/s00345-023-04548-z
  • Pensabene M, Cimador M, Spataro B, et al. Intraoperative ultrasound-assisted endoscopic treatment of primary intermediate and high-grade vesicoureteral reflux in children in a long-term follow-up. J Pediatric Urology. 2024;20(1):132.e1–132.e11. doi:10.1016/j.jpurol.2023.10.008
  • Renaux-Petel M, Grynberg L, Lubet A, Comte D, Liard-Zmuda A. Vantris vs. deflux for treatment of paediatric vesicoureteral reflux: efficacy and obstruction risk. French J Urology. 2024;34(2):102585. doi:10.1016/j.fjurol.2024.102585
  • Arceo-Olaiz RA, Scherz HC, Kirsch AJ. Endoscopic treatment of VUR. Urology Video J. 2022;15:100163. doi:10.1016/j.urolvj.2022.100163
  • Cerwinka WH, Scherz HC, Kirsch AJ. Dynamic hydrodistention classification of the ureter and the double HIT method to correct vesicoureteral reflux. Arch Esp Urol. 2008;61(8). doi:10.4321/S0004-06142008000800005
  • Kirsch AJ, Arlen AM. Evaluation of new Deflux administration techniques: intraureteric HIT and Double HIT for the endoscopic correction of vesicoureteral reflux. Expert Rev Med Dev. 2014;11(5):439–446. doi:10.1586/17434440.2014.929491
  • Report of the International Reflux Study Committee. Medical versus surgical treatment of primary vesicoureteral reflux: Report of the international reflux study committee. Pediatrics. 1981;67(3):392–400. doi:10.1542/peds.67.3.392
  • Yap TL, Chen Y, Nah SA, Ong CCP, Jacobsen A, Low Y. STING versus HIT technique of endoscopic treatment for vesicoureteral reflux: a systematic review and meta-analysis. J Pediatric Surg. 2016;51(12):2015–2020. doi:10.1016/j.jpedsurg.2016.09.028
  • Läckgren G, Wåhlin N, Sköldenberg E, Stenberg A. Long-term followup of children treated with dextranomer/hyaluronic acid copolymer for vesicoureteral reflux. J Urol. 2001;166(5):1887–1892. doi:10.1016/s0022-5347(05)65713-8
  • Chertin B, Caluwé D D, Puri P. Endoscopic treatment of primary grades iv and v vesicoureteral reflux in children with subureteral injection of Polytetrafluoroethylene. J Urol. 2003;169(5):1847–1849. doi:10.1097/01.ju.0000062300.71507.3a
  • Puri P, Ninan GK, Surana R. Subureteric Teflon Injection(STING). Eur Urol. 1995;27(1):71–75. doi:10.1159/000475128
  • Stenberg A, Lackgren G. A new bioimplant for the endoscopic treatment of vesicoureteral reflux: experimental and short-term clinical results. J Urol. 1995;154:800–803. doi:10.1097/00005392-199508000-00127
  • Selvi I, Canbaz FA, Dönmez Mİ, et al. Does pre-fellowship experience alter success rates of endoscopic treatment of vesicoureteral reflux during pediatric urology fellowship? J Pediatric Urology. 2022;18(4):527.e1–527.e8. doi:10.1016/j.jpurol.2022.06.001
  • Routh JC, Reinberg Y, Ashley RA, et al. Multivariate comparison of the efficacy of intraureteral versus subtrigonal techniques of dextranomer/hyaluronic acid injection. J Urol. 2007;178(4S):1702–1706. doi:10.1016/j.juro.2007.03.174
  • Thomas JC. Vesicoureteral Reflux and Duplex Systems. Adv Urology. 2008;2008:1–3. doi:10.1155/2008/651891
  • Läckgren G, Wåhlin N, Sköldenberg E, Nevéus T, Stenberg A. Endoscopic treatment of vesicoureteral reflux with dextranomer/hyaluronic acid copolymer is effective in either double ureters or a small kidney. J Urol. 2003;170(4 Part 2):1551–1555. doi:10.1097/01.ju.0000084672.98131.f7
  • Chertin B, Mohanan N, Farkas A, Puri P. Endoscopic treatment of vesicoureteral reflux associated with ureterocele. J Urol. 2007;178(4S):1594–1597. doi:10.1016/j.juro.2007.03.170
  • Cerwinka WH, Scherz HC, Kirsch AJ. Endoscopic treatment of vesicoureteral reflux associated with paraureteral diverticula in children. J Urol. 2007;178(4):1469–1473. doi:10.1016/j.juro.2007.05.168
  • Sillén U. Bladder dysfunction in children with vesico-ureteric reflux. Acta Paediatr Suppl. 1999;88(431):40–47. doi:10.1111/j.1651-2227.1999.tb01317.x
  • Soygür T, Arikan N, Yesillii Ç, Göğüş O. Relationship among pediatric voiding dysfunction and vesicoureteral reflux and renal scars. Urology. 1999;54(5):905–908. doi:10.1016/S0090-4295(99)00291-5
  • Lavelle MT, Conlin MJ, Skoog SJ. Subureteral injection of Deflux for correction of reflux: analysis of factors predicting success. Urology. 2005;65(3):564–567. doi:10.1016/j.urology.2004.09.068
  • Capozza N, Lais A, Matarazzo E, Nappo S, Patricolo M, Caione P. Influence of voiding dysfunction on the outcome of endoscopic treatment for vesicoureteral reflux. J Urol. 2002;168(4 Pt 2):1695–1698. doi:10.1016/S0022-5347(05)64391-1